m subst'ing test msgs per WP:SUBST |
No edit summary |
||
Line 6: | Line 6: | ||
I deleted [[User:Arion/monobook.js]] since it was clearly meant to assist in moving articles to improper names. -- [[User:Jitse Niesen|Jitse Niesen]] ([[User talk:Jitse Niesen|talk]]) 11:32, 4 September 2005 (UTC) |
I deleted [[User:Arion/monobook.js]] since it was clearly meant to assist in moving articles to improper names. -- [[User:Jitse Niesen|Jitse Niesen]] ([[User talk:Jitse Niesen|talk]]) 11:32, 4 September 2005 (UTC) |
||
== Please put this on the Talk:Homeopathy Page and mention it is posted by me == |
|||
Dear Scientizzle,<br> |
|||
Please put this on the Talk:Homeopathy Page and mention it is posted by me (or else the others may think I've bribed you); I'm not yet able to post there directly myself because the Page is semi-writeprotected.<br> |
|||
Here are some of the studies/clinical trials:-</p> |
|||
<b> |
|||
<p align="left">STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES</p> |
|||
<div align="left"> |
|||
<table height="172" width="678" border="1"> |
|||
<tr> |
|||
<td width="171" height="9"><font size="1">ORIGINAL/TRANSLATED TITLE</font></td> |
|||
<td width="128" height="9">AUTHOR(S)</td> |
|||
<td width="84" height="9">PUBLICATION</td> |
|||
<td width="92" height="9">ACTIVITY</td> |
|||
<td width="203" height="9">STUDY</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="9"><font face="Optima-Bold" size="1"><b> |
|||
<p align="left">Inhibition of lymphoblast</b></font></b> <font face="Optima-Bold" size="1"><b>transformation |
|||
test (LTT) in</b></font> <font face="Optima-Bold" size="1"><b>phytohaemagglutinin |
|||
(PHA) with</b></font> <font face="Optima-Bold" size="1"><b>Phytolacca |
|||
americana in</b></font> <b><font face="Optima-Bold" size="1">homeopathic |
|||
dilution</font></b></p> |
|||
</td> |
|||
<td width="128" height="9"><font face="Optima" size="1"> |
|||
<p align="left">Colas H.,</p> |
|||
<p align="left">Aubin M.,</p> |
|||
<p align="left">Picard P.,</p> |
|||
<p align="left">Lebecq J.C.</font></p> |
|||
</td> |
|||
<td width="84" height="9"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Ann. Homéopat.</p> |
|||
<p align="left">Fr.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1975</font></b><font face="Optima" size="1">, |
|||
6: 1-11.</font></p> |
|||
</td> |
|||
<td width="92" height="9"><b> |
|||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> |
|||
</td> |
|||
<td width="203" height="9"> |
|||
<p align="left"><font face="Optima" size="1">Lymphoblast</p> |
|||
<p align="left">transformation</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="9"><font face="Optima-Bold" size="1"><b> |
|||
<p align="left">Inquiry into the limits of biological</b></font> <font face="Optima-Bold" size="1"><b>effects |
|||
of chemical compounds in</b></font> <font face="Optima-Bold" size="1"><b>tissue |
|||
culture. I. Low dose effects of</b></font> <b><font face="Optima-Bold" size="1">mercure |
|||
chloride</font></b></p> |
|||
</td> |
|||
<td width="128" height="9"><font face="Optima" size="1"> |
|||
<p align="left">Mansvelt J.D.,</p> |
|||
<p align="left">van Amons E.</font></p> |
|||
</td> |
|||
<td width="84" height="9"> |
|||
<p align="left"><i><font face="Optima-Oblique" size="1">Z. |
|||
Naturtorschung</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1975</font></b><font face="Optima" size="1">, 30:</p> |
|||
<p align="left">643-649.</font></p> |
|||
</td> |
|||
<td width="92" height="9"><b> |
|||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> |
|||
</td> |
|||
<td width="203" height="9"><font face="Optima" size="1"> |
|||
<p align="left">Lymphocyte</p> |
|||
<p align="left">growth</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="9"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">The effects of Belladonna and</font></b> <font face="Optima-Bold" size="1"><b>Ferrum |
|||
phosphoricum on the</b></font> <font face="Optima-Bold" size="1"><b>chemoluminescence |
|||
of human</b></font> <b><font face="Optima-Bold" size="1">poly-morphonuclear |
|||
neutrophils</font></b></p> |
|||
</td> |
|||
<td width="128" height="9"><font face="Optima" size="1"> |
|||
<p align="left">Poitevin B.,</p> |
|||
<p align="left">Aubin M.,</p> |
|||
<p align="left">Royer J.F.</font></p> |
|||
</td> |
|||
<td width="84" height="9"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Ann. Homéop. Fr.</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1983</font></b><font face="Optima" size="1">, 3: 5-12.</font></p> |
|||
</td> |
|||
<td width="92" height="9"><b> |
|||
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p> |
|||
</td> |
|||
<td width="203" height="9"><font face="Optima" size="1">Radical release</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Effect of aconitum and veratrum</p> |
|||
<p align="left">on the isolated perfused heart of</p> |
|||
<p align="left">the common eel </font></b><font face="Optima" size="1">(Anguilla |
|||
anguilla)</font></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Pennec J.P.,</p> |
|||
<p align="left">Aubin M.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Comp. Biochem.</p> |
|||
<p align="left">Physiol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">776: 367-369.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Elements of homeopathic</p> |
|||
<p align="left">pharmacology</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Aubin M.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Homéopathie</p> |
|||
<p align="left">Franç.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">, |
|||
72:</p> |
|||
<p align="left">231- 235</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">The effect of homeopathic</p> |
|||
<p align="left">preparations on the phagocyte</p> |
|||
<p align="left">activity of granulocytes. In vitro</p> |
|||
<p align="left">tests and double-blind controlled</p> |
|||
<p align="left">trials</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Wagner H.,</p> |
|||
<p align="left">Jurcic K.,</p> |
|||
<p align="left">Doenicke A.,</p> |
|||
<p align="left">Rosenhuber E.,</p> |
|||
<p align="left">Behrens N.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Arzneim.</p> |
|||
<p align="left">Forsch./Drug Res.</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1986</font></b><font face="Optima" size="1">, 36:</p> |
|||
<p align="left">1424-1425.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1">Phagocytosis</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Approach to quantitative analysis</p> |
|||
<p align="left">of the effect of Apis mellifica on</p> |
|||
<p align="left">the degranulation of human</p> |
|||
<p align="left">basophils cultivated in vitro</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Poitevin B.,</p> |
|||
<p align="left">Aubin M.,</p> |
|||
<p align="left">Benveniste J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Innov. Tech. Biol.</p> |
|||
<p align="left">Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1986</font></b><font face="Optima" size="1">, |
|||
7:</p> |
|||
<p align="left">64-68.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Basophil</p> |
|||
<p align="left">degranulation</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">In vitro stimulation of human</font></b> <b><font face="Optima-Bold" size="1">granulocytes |
|||
and lymphocytes by</font></b> <font face="Optima-Bold" size="1"><b>pico- |
|||
and femtogram quantities of</b></font> <b><font face="Optima-Bold" size="1">cytostatic |
|||
agents</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Wagner H.,</p> |
|||
<p align="left">Kreher B.,</p> |
|||
<p align="left">Jurcic K.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><font face="Optima-Oblique" size="1"><i> |
|||
<p align="left">Arzneim.</i></font> <b><font face="Optima-Oblique" size="1"><i>Forsch./Drug |
|||
Res.</i></font><font face="Optima" size="1">,</font></b> <b><font face="Optima-Bold" size="1">1988</font><font face="Optima" size="1">, |
|||
38:</font></b> <b><font face="Optima" size="1">273-275.</font></b></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Lymphocyte</p> |
|||
<p align="left">growth</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Human basophil degranulation</font></b> <b><font face="Optima-Bold" size="1">triggered |
|||
by very dilute antiserum</font></b> <b><font face="Optima-Bold" size="1">against |
|||
IgE</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Davenas E.,</font> <font face="Optima" size="1"><b>Beauvais |
|||
F.,</b></font> <font face="Optima" size="1"><b>Amara J.,</b></font> <font face="Optima" size="1"><b>Robinson |
|||
M.,</b></font> <font face="Optima" size="1"><b>Miadonna A.,</b></font> <font face="Optima" size="1"><b>Tedeschi |
|||
A.,</b></font> <font face="Optima" size="1"><b>Pomeranz B.,</b></font> <font face="Optima" size="1"><b>Fortner |
|||
P.,</b></font> <font face="Optima" size="1"><b>Belon P.,</b></font> <font face="Optima" size="1"><b>Sainte-Laudy |
|||
J.,</b></font> <font face="Optima" size="1"><b>Poitevin B.,</b></font> <b><font face="Optima" size="1">Benveniste |
|||
J.</font></b></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Nature</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">333: 816-818.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Basophils</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><font face="Optima" size="1"> |
|||
<p align="left"></font><b><font face="Optima-Bold" size="1">In vitro |
|||
immunological</p> |
|||
<p align="left">degranulation of human basophils</p> |
|||
<p align="left">is modulated by lung histamine</p> |
|||
<p align="left">and Apis mellifica</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Poitevin B.,</p> |
|||
<p align="left">Davenas E.,</p> |
|||
<p align="left">Benveniste J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Brit. J. Clin.</p> |
|||
<p align="left">Pharmacol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">25: 439-444.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Basophil</p> |
|||
<p align="left">degranulation</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Cytotoxic agents as</p> |
|||
<p align="left">immunomodulators</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Wagner H.,</p> |
|||
<p align="left">Kreher B.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Proc. of the 3rd</p> |
|||
<p align="left">GIRI meeting</font></i><font face="Optima" size="1">,</p> |
|||
<p align="left">Paris, </font><b><font face="Optima-Bold" size="1">1989</font></b><font face="Optima" size="1">, |
|||
31-</p> |
|||
<p align="left">46.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Lymphocyte</p> |
|||
<p align="left">growth</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Contributions of fundamental</p> |
|||
<p align="left">research in homeopathy</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Boiron J.,</p> |
|||
<p align="left">Belon P.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1990</font></b><font face="Optima" size="1">, 1: 34-35.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Basophil</p> |
|||
<p align="left">degranulation</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Synergism of action between</p> |
|||
<p align="left">indoleacetic acid (IAA) and highly</p> |
|||
<p align="left">diluted solutions of CaCO3 on the</p> |
|||
<p align="left">growth of oat coleoptiles</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1">Bornoroni C.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1991</font></b><font face="Optima" size="1">, 1 (4/5):</p> |
|||
<p align="left">275-278.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Growth of plant</p> |
|||
<p align="left">cells</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Study of the action of</p> |
|||
<p align="left">Hahnemannian dilutions of</p> |
|||
<p align="left">mercury chloride on the mitotic</p> |
|||
<p align="left">index in animal cell cultures.</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Boiron J.,</p> |
|||
<p align="left">Abecassis J.,</p> |
|||
<p align="left">Cotte J.,</p> |
|||
<p align="left">Bernard A.M.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Ann. Homéop.</p> |
|||
<p align="left">Fr</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1991</font></b><font face="Optima" size="1">, |
|||
23:</p> |
|||
<p align="left">43-49.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1">Hg toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Dual effects of formylpeptides on</p> |
|||
<p align="left">the adhesion of endotoxin-primed</p> |
|||
<p align="left">human neutrophils</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Bellavite P.,</p> |
|||
<p align="left">Chirumbolo S.,</p> |
|||
<p align="left">Lippi G.,</p> |
|||
<p align="left">Andrioli G.,</p> |
|||
<p align="left">Bonazzi L.,</p> |
|||
<p align="left">Ferro I.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Cell. Biochem.</p> |
|||
<p align="left">Funct.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">, |
|||
11:</p> |
|||
<p align="left">231-239.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Cell adhesion</p> |
|||
<p align="left">(bact. pept.</p> |
|||
<p align="left">10-8-10-9)</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Effects of homeopathic</p> |
|||
<p align="left">preparations of organic acids and</p> |
|||
<p align="left">of minerals on the oxidative</p> |
|||
<p align="left">metabolism of human neutrophils</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Chirumbolo S.,</p> |
|||
<p align="left">Signorini A.,</p> |
|||
<p align="left">Bianchi I.,</p> |
|||
<p align="left">Lippi G.,</p> |
|||
<p align="left">Bellavite P.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">82: 227-244.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Leucocyte</p> |
|||
<p align="left">activation</p> |
|||
<p align="left">(metabolism)</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Platelets/endothelial cells</p> |
|||
<p align="left">interactions in presence of</p> |
|||
<p align="left">acetylsalicylic acid at ultra low</p> |
|||
<p align="left">dose</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Doutremepuich</p> |
|||
<p align="left">C.,</p> |
|||
<p align="left">Lalanne M.C.,</p> |
|||
<p align="left">Ramboer I.,</p> |
|||
<p align="left">Sertillanges</p> |
|||
<p align="left">M.N.,</p> |
|||
<p align="left">De Seze O.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Omeomed 92 (C.</p> |
|||
<p align="left">Bornoroni, ed.)</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1993</font></b><font face="Optima" size="1">, Editrice</p> |
|||
<p align="left">Compositori,</p> |
|||
<p align="left">Bologna:</p> |
|||
<p align="left">109-115.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Prostacyclin</p> |
|||
<p align="left">release</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Effect of high dilutions of epidermal</p> |
|||
<p align="left">growth factor (EGF) on </font><i><font face="Optima-BoldOblique" size="1">in |
|||
vitro</p> |
|||
</font></i><font face="Optima-Bold" size="1"> |
|||
<p align="left">proliferation of keratinocyte and</p> |
|||
<p align="left">fibroblast cell lines</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Fougeray S.,</p> |
|||
<p align="left">Moubry K.,</p> |
|||
<p align="left">Vallot N.,</p> |
|||
<p align="left">Bastide M.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">82: 124-125.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Growth of</p> |
|||
<p align="left">keratinocytes</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Effects of different homeopathic</p> |
|||
<p align="left">potencies of Lachesis on</p> |
|||
<p align="left">lymphocyte cultures obtained</p> |
|||
<p align="left">from rabbit blood</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Enbergs H.,</p> |
|||
<p align="left">Arndt G.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Biol. Tier., </font><b><font face="Optima-BoldOblique" size="1">1993</font></b><font face="Optima-Oblique" size="1">,</p> |
|||
<p align="left">4.</font></i></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Mitotic and</p> |
|||
<p align="left">immunostimulating</p> |
|||
<p align="left">activity (bact. pept</p> |
|||
<p align="left">10-5-10-6)</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">The effect of homeopathic</p> |
|||
<p align="left">potencies of housedust mite on</p> |
|||
<p align="left">the migration of house-dust sensitive</p> |
|||
<p align="left">human leukocytes</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Gibson S.L.,</p> |
|||
<p align="left">Gibson R.G.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Complement.</p> |
|||
<p align="left">Ther. Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">4: 169-171.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Leucocyte</p> |
|||
<p align="left">chemotaxis</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">The effects of Nux vomica</p> |
|||
<p align="left">Homaccord and Atropinum comp.</p> |
|||
<p align="left">on intestinal activity in vitro</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Kanui T.I.,</p> |
|||
<p align="left">Enbergs H.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Biol. Tier.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">/1,</p> |
|||
<p align="left">43-47.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Contraction of</p> |
|||
<p align="left">intestinal muscles</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Application of flow cytometry to</p> |
|||
<p align="left">the analysis of the</p> |
|||
<p align="left">immunosuppressive effect of</p> |
|||
<p align="left">histamine dilutions on human</p> |
|||
<p align="left">basophil action: effect of</p> |
|||
<p align="left">cimetidine</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Sainte-Laudy J.,</p> |
|||
<p align="left">Belon P.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Inflamm. Res</font></i><font face="Optima" size="1">.,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">1997</font></b><font face="Optima" size="1">, 46:</p> |
|||
<p align="left">S27-S28.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Basophil</p> |
|||
<p align="left">degranulation</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Effects of Podophillum pellatum</p> |
|||
<p align="left">compounds in various</p> |
|||
<p align="left">preparations and dilutions on</p> |
|||
<p align="left">human neutrophil functions in</p> |
|||
<p align="left">vitro</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Chirumbolo S.,</p> |
|||
<p align="left">Conforti A.,</p> |
|||
<p align="left">Lussignoli S.,</p> |
|||
<p align="left">Metelmann H.</p> |
|||
<p align="left">et Al.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Br. Hom. J</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">;</p> |
|||
<p align="left">86-16.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Release of</p> |
|||
<p align="left">superoxides</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><i><font face="Optima-BoldOblique" size="1"> |
|||
<p align="left">In vivo </font></i><font face="Optima-Bold" size="1">and |
|||
</font><i><font face="Optima-BoldOblique" size="1">in vitro </font></i><font face="Optima-Bold" size="1">studies |
|||
on the</p> |
|||
<p align="left">efficiency of potentized and nonpotentized</p> |
|||
<p align="left">substances</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">, |
|||
2;</p> |
|||
<p align="left">40-46.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Difference between</p> |
|||
<p align="left">potentised and</p> |
|||
<p align="left">non-potentised</p> |
|||
<p align="left">substances</font></p> |
|||
</td> |
|||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">In vivo </font></i><font face="Optima" size="1">and </font><i><font face="Optima-Oblique" size="1">in</p> |
|||
<p align="left">vitro </font></i><font face="Optima" size="1">study; |
|||
basic</p> |
|||
<p align="left">research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Experiments with the effects of</p> |
|||
<p align="left">Ubichinon-Injeel and strong</p> |
|||
<p align="left">Ubichinon-Injeel on an acellular</p> |
|||
<p align="left">system</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">, |
|||
3;</p> |
|||
<p align="left">99-104.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Different effects of</p> |
|||
<p align="left">associations of</p> |
|||
<p align="left">various potencies and</p> |
|||
<p align="left">individual potencies</font></p> |
|||
</td> |
|||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> |
|||
<p align="left">basic research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Efficacy of the homeopathic drugs</p> |
|||
<p align="left">Suis and Arnica comp.-Heel® on</p> |
|||
<p align="left">lymphocyte and phagocyte</p> |
|||
<p align="left">activity</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1">Enbergs H.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, |
|||
1;</p> |
|||
<p align="left">3-11.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Effect of</p> |
|||
<p align="left">organotherapeutics</p> |
|||
<p align="left">and Arnica comp. -</p> |
|||
<p align="left">Heel® on immune</p> |
|||
<p align="left">system cells</font></p> |
|||
</td> |
|||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> |
|||
<p align="left">basic research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Influence of dilutions and</p> |
|||
<p align="left">potencies of cAMP on different</p> |
|||
<p align="left">enzymatic systems</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, |
|||
2;</p> |
|||
<p align="left">55-62.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Effects of dilutions</p> |
|||
<p align="left">and potencies of</p> |
|||
<p align="left">cAMP on some</p> |
|||
<p align="left">enzymatic activities</font></p> |
|||
</td> |
|||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> |
|||
<p align="left">basic research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Studies of the principles of</p> |
|||
<p align="left">homeopathy; the changeover</p> |
|||
<p align="left">from </font><i><font face="Optima-BoldOblique" size="1">in |
|||
vivo </font></i><font face="Optima-Bold" size="1">to </font><i><font face="Optima-BoldOblique" size="1">in |
|||
vitro</p> |
|||
</font></i><font face="Optima-Bold" size="1"> |
|||
<p align="left">experimental research</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">, |
|||
3;</p> |
|||
<p align="left">98-103.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Potentised and</p> |
|||
<p align="left">non-potentised</p> |
|||
<p align="left">dilutions are</p> |
|||
<p align="left">equally effective,</p> |
|||
<p align="left">but have different</p> |
|||
<p align="left">actions</font></p> |
|||
</td> |
|||
<td width="203" height="8"> |
|||
<p align="left"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic |
|||
research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><font face="Optima-Bold" size="1"><b> |
|||
<p align="left">Determination of the activity of</b></font> <b><font face="Optima-Bold" size="1">acid |
|||
phosphatase with cAMP at</font></b> <b><font face="Optima-Bold" size="1">various |
|||
potencies</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, |
|||
1; 4-8.</font></td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Different effects on</font> <font face="Optima" size="1">enzymatic |
|||
activity</font></p> |
|||
</td> |
|||
<td width="203" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p> |
|||
<p align="left">basic research</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Contribution to study of the</p> |
|||
<p align="left">efficacy of homeopathic potencies</p> |
|||
<p align="left">of phosphorus</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1">Gomez J.C.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, |
|||
2;</p> |
|||
<p align="left">53-57.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Effect of different</p> |
|||
<p align="left">potencies of</p> |
|||
<p align="left">phosphorus</font></p> |
|||
</td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Tests on guinea</p> |
|||
<p align="left">pigs</font></p> |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Determination of the activity of</p> |
|||
<p align="left">acid phosphatase in the presence</p> |
|||
<p align="left">of Ubichinon comp.</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Harisch G.,</p> |
|||
<p align="left">Dittmann J.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, |
|||
4;</p> |
|||
<p align="left">188-194.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Effect of enzymatic</p> |
|||
<p align="left">activity of</p> |
|||
<p align="left">homeopathic</p> |
|||
<p align="left">medicine</font></p> |
|||
</td> |
|||
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic |
|||
research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Biochemical efficacy of</p> |
|||
<p align="left">homeopathic and electronic</p> |
|||
<p align="left">preparations of D8 potassium</p> |
|||
<p align="left">cyanate</font></b></p> |
|||
</td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Dittmann J.,</p> |
|||
<p align="left">Kanapin H.,</p> |
|||
<p align="left">Harisch G.</font></p> |
|||
</td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">FKM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, |
|||
6;</p> |
|||
<p align="left">15-18.</font></p> |
|||
</td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Homeopathic</p> |
|||
<p align="left">potentisation is</p> |
|||
<p align="left">more effective than</p> |
|||
<p align="left">electronic</p> |
|||
<p align="left">potentisation</font></p> |
|||
</td> |
|||
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic |
|||
research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Osteoporosis in vitro in rat tibiaderived</p> |
|||
<p align="left">osteoblasts is promoted</p> |
|||
<p align="left">by the homeopathic preparation,</p> |
|||
<p align="left">FMS Calciumfluor</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Palermo C.,</p> |
|||
<p align="left">Filanti C.,</p> |
|||
<p align="left">Poggi S.,</p> |
|||
<p align="left">Manduca P.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Cell Biol Int</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,</p> |
|||
<p align="left">23(1): 31-40.</font></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Osteogenesis</p> |
|||
<p align="left">(trial with</p> |
|||
<p align="left">compound drug)</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="32" rowspan="2"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Thin-layer chromatography (TLC)</p> |
|||
<p align="left">of homeopathic active</p> |
|||
<p align="left">constituents</font></b></td> |
|||
<td width="128" height="32" rowspan="2"><font face="Optima" size="1">Schmolz |
|||
M.</font></td> |
|||
<td width="84" height="32" rowspan="2"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">, |
|||
5;</p> |
|||
<p align="left">248-250.</font></td> |
|||
<td width="92" height="16"><font face="Optima" size="1"> |
|||
<p align="left">Constituents of</font> <font face="Optima" size="1">Arnica |
|||
comp.-</font> <font face="Optima" size="1">Heel® ointment:</font> <font face="Optima" size="1">electrophoresis</font> |
|||
<font face="Optima" size="1">accelerates their</font> <font face="Optima" size="1">skin |
|||
penetration.</font> </td> |
|||
<td width="203" height="32"><font face="Optima" size="1">Basic research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="92" height="16"><font face="Optima" size="1">Effect of</font> <font face="Optima" size="1">homeopathic</font> |
|||
<font face="Optima" size="1">constituents on</font> <font face="Optima" size="1">enzymatic |
|||
activity.</font></td> |
|||
<td width="203" height="4"><font face="Optima" size="1">Basic research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Efficacy of a potentised</p> |
|||
<p align="left">homeopathic drug in reducing</p> |
|||
<p align="left">cytotoxic effects produced by</p> |
|||
<p align="left">arsenic trioxide in mice</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Datta S.,</p> |
|||
<p align="left">Mallick P.,</p> |
|||
<p align="left">Bukhsh A.R.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Complement Ther</p> |
|||
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999 |
|||
</font></b><font face="Optima" size="1">Jan;</p> |
|||
<p align="left">7 (8): 62-75 </font><b><font face="Optima-Bold" size="1">(a).</font></b></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Arsenic trioxide</p> |
|||
<p align="left">toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Efficacy of a potentised</p> |
|||
<p align="left">homeopathic drug in reducing</p> |
|||
<p align="left">cytotoxic effects produced by</p> |
|||
<p align="left">arsenic trioxide in mice</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Datta S.,</p> |
|||
<p align="left">Mallick P.,</p> |
|||
<p align="left">Bukhsh A.R.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Complement Ther</p> |
|||
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999 |
|||
</font></b><font face="Optima" size="1">Sep;</p> |
|||
<p align="left">7 (3): 156-63 </font><b><font face="Optima-Bold" size="1">(b).</font></b></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Arsenic trioxide</p> |
|||
<p align="left">toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><font face="Optima-Bold" size="1"><b> |
|||
<p align="left">Non-cytotoxic antiviral action of</b></font> <font face="Optima-Bold" size="1"><b>a |
|||
homeopathic drug</b></font></td> |
|||
<td width="128" height="8"><font face="Optima" size="1">Heine H.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Ärzteitschrift für</p> |
|||
<p align="left">Neturheilverfahre</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">2000</font></b><font face="Optima" size="1">; 41: 542-7.</font></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Symbol" size="1"> |
|||
<p align="left">ã </font><font face="Optima" size="1">interferon</p> |
|||
<p align="left">synthesis</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Efficacy of a potentised</p> |
|||
<p align="left">homeopathic drug in reducing</p> |
|||
<p align="left">cytotoxic effects produced by</p> |
|||
<p align="left">arsenic trioxide in mice</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Kundu S.N.,</p> |
|||
<p align="left">Mitra K.,</p> |
|||
<p align="left">Khuda</p> |
|||
<p align="left">Bukhsh A.R.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Complement Ther</p> |
|||
<p align="left">Med </font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000 |
|||
</font></b><font face="Optima" size="1">Sep;</p> |
|||
<p align="left">1 (3): 157-65.</font></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Arsenic trioxide</p> |
|||
<p align="left">toxicity</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Stimulatory effect of some plant</p> |
|||
<p align="left">extracts used in homeopathy on</p> |
|||
<p align="left">the phagocytosis induced</p> |
|||
<p align="left">chemiluminescence of</p> |
|||
<p align="left">polymorphonuclear leukocytes</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Crocnan D.,</p> |
|||
<p align="left">Greabu M.,</p> |
|||
<p align="left">Olinescu R.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Rocz Akad Med</p> |
|||
<p align="left">Biochemist</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">;</p> |
|||
<p align="left">45: 246-254.</font></td> |
|||
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td> |
|||
<td width="203" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Phagocytosis</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="8"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Difference between the efficacy</p> |
|||
<p align="left">of single potencies and chords</font></b></td> |
|||
<td width="128" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Dittmann J.,</p> |
|||
<p align="left">Harisch G.</font></td> |
|||
<td width="84" height="8"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, |
|||
1;</p> |
|||
<p align="left">18-23.</font></td> |
|||
<td width="92" height="8"><font face="Optima" size="1"> |
|||
<p align="left">Potency chords are</p> |
|||
<p align="left">more effective than</p> |
|||
<p align="left">single potencies</font></td> |
|||
<td width="203" height="8"><font face="Optima" size="1">Basic research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="28"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Influence of some homeopathic</p> |
|||
<p align="left">drugs on the catalytic activity of</p> |
|||
<p align="left">uricase, acid phosphatase and the</p> |
|||
<p align="left">cytosol glutathion-S-transferase</font></b></td> |
|||
<td width="128" height="28"><font face="Optima" size="1"> |
|||
<p align="left">Dittmann J.,</p> |
|||
<p align="left">Kanapin H.,</p> |
|||
<p align="left">Harisch G.</font></td> |
|||
<td width="84" height="28"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, |
|||
3;</p> |
|||
<p align="left">125-131</font></td> |
|||
<td width="92" height="28"><font face="Optima" size="1"> |
|||
<p align="left">Effect of D8</p> |
|||
<p align="left">potencies on three</p> |
|||
<p align="left">different enzymatic</p> |
|||
<p align="left">systems</font></td> |
|||
<td width="203" height="28"><font face="Optima" size="1">Basic research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="37"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Influence of some homeopathic</p> |
|||
<p align="left">drugs on the catalytic activity of</p> |
|||
<p align="left">cAMP-dependent protein kinases</font></b></td> |
|||
<td width="128" height="37"><font face="Optima" size="1"> |
|||
<p align="left">Dittmann J.,</p> |
|||
<p align="left">Kanapin H.,</p> |
|||
<p align="left">Harisch G.</font></td> |
|||
<td width="84" height="37"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">, |
|||
6;</p> |
|||
<p align="left">289-296.</font></td> |
|||
<td width="92" height="37"><font face="Optima" size="1"> |
|||
<p align="left">Effect of different</p> |
|||
<p align="left">potencies of 5</p> |
|||
<p align="left">substances on</p> |
|||
<p align="left">enzymatic activity</font></td> |
|||
<td width="203" height="37"><font face="Optima" size="1">Basic research</font></td> |
|||
</tr> |
|||
<tr> |
|||
<td width="171" height="38"><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">Neuroprotection from glutamate</p> |
|||
<p align="left">toxicity with ultra-low dose</p> |
|||
<p align="left">glutamate</font></b></td> |
|||
<td width="128" height="38"> |
|||
<p align="left"><font face="Optima" size="1">Jonas W.,</p> |
|||
<p align="left">Lin Y.,</p> |
|||
<p align="left">Zortella F.</font></td> |
|||
<td width="84" height="38"><i><font face="Optima-Oblique" size="1"> |
|||
<p align="left">Neuroreport</font></i><font face="Optima" size="1">,</p> |
|||
</font><b><font face="Optima-Bold" size="1"> |
|||
<p align="left">2001 </font></b><font face="Optima" size="1">Feb 92; 12</p> |
|||
<p align="left">(2): 335-9.</font></td> |
|||
<td width="92" height="38"><b><font face="Optima-Bold" size="1">Protective</font></b></td> |
|||
<td width="203" height="38"><font face="Optima" size="1">Glutamate |
|||
toxicity</font></td> |
|||
</tr> |
|||
</table> |
|||
</div> |
|||
<font face="Optima" size="1"> |
|||
<p align="left"> </p> |
|||
<p align="left">KEY: BT = Biomedical Therapy</p> |
|||
<p align="left">BM = Biologische Medizin</p> |
|||
<p align="left">FKM = Forschung Komplementär Medizin</p> |
|||
</font></font></font></font></font></font></font></font>[[User:Ramaanand|Ramaanand]] ([[User talk:Ramaanand|talk]]) 02:14, 17 March 2008 (UTC)Dr.Jhingadé |
Revision as of 02:14, 17 March 2008
Please stop adding nonsense to Wikipedia. It is considered vandalism. If you were just trying to experiment, then use the sandbox instead. Thank you. --W(t) 02:51, 2005 May 23 (UTC)
Please stop. If you continue to vandalize pages, you will be blocked from editing Wikipedia. Mindspillage (spill yours?) 02:51, 23 May 2005 (UTC)
Please don't move articles to strange names where no one will expect them. NoAccount
I deleted User:Arion/monobook.js since it was clearly meant to assist in moving articles to improper names. -- Jitse Niesen (talk) 11:32, 4 September 2005 (UTC)
Please put this on the Talk:Homeopathy Page and mention it is posted by me
Dear Scientizzle,
Please put this on the Talk:Homeopathy Page and mention it is posted by me (or else the others may think I've bribed you); I'm not yet able to post there directly myself because the Page is semi-writeprotected.
Here are some of the studies/clinical trials:-
STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES
ORIGINAL/TRANSLATED TITLE | AUTHOR(S) | PUBLICATION | ACTIVITY | STUDY |
Inhibition of lymphoblast transformation test (LTT) in phytohaemagglutinin (PHA) with Phytolacca americana in homeopathic dilution |
Colas H., Aubin M., Picard P., Lebecq J.C. |
Ann. Homéopat. Fr., 1975, 6: 1-11. |
Inhibitory |
Lymphoblast transformation |
Inquiry into the limits of biological effects of chemical compounds in tissue culture. I. Low dose effects of mercure chloride |
Mansvelt J.D., van Amons E. |
Z. Naturtorschung, 1975, 30: 643-649. |
Inhibitory |
Lymphocyte growth |
The effects of Belladonna and Ferrum phosphoricum on the chemoluminescence of human poly-morphonuclear neutrophils |
Poitevin B., Aubin M., Royer J.F. |
Ann. Homéop. Fr., 1983, 3: 5-12. |
Inhibitory |
Radical release |
Effect of aconitum and veratrum on the isolated perfused heart of the common eel (Anguilla anguilla) |
Pennec J.P., Aubin M. |
Comp. Biochem. Physiol., 1984, 776: 367-369. |
Protective | Aconitine toxicity |
Elements of homeopathic pharmacology |
Aubin M. |
Homéopathie Franç., 1984, 72: 231- 235 |
Protective | Aconitine toxicity |
The effect of homeopathic preparations on the phagocyte activity of granulocytes. In vitro tests and double-blind controlled trials |
Wagner H., Jurcic K., Doenicke A., Rosenhuber E., Behrens N. |
Arzneim. Forsch./Drug Res., 1986, 36: 1424-1425. |
Stimulant | Phagocytosis |
Approach to quantitative analysis of the effect of Apis mellifica on the degranulation of human basophils cultivated in vitro |
Poitevin B., Aubin M., Benveniste J. |
Innov. Tech. Biol. Med., 1986, 7: 64-68. |
Inhibitory |
Basophil degranulation |
In vitro stimulation of human granulocytes and lymphocytes by pico- and femtogram quantities of cytostatic agents |
Wagner H., Kreher B., Jurcic K. |
Arzneim. Forsch./Drug Res., 1988, 38: 273-275. |
Stimulant |
Lymphocyte growth |
Human basophil degranulation triggered by very dilute antiserum against IgE |
Davenas E., Beauvais F., Amara J., Robinson M., Miadonna A., Tedeschi A., Pomeranz B., Fortner P., Belon P., Sainte-Laudy J., Poitevin B., Benveniste J. |
Nature, 1988, 333: 816-818. |
Stimulant |
Basophils |
In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica |
Poitevin B., Davenas E., Benveniste J. |
Brit. J. Clin. Pharmacol., 1988, 25: 439-444. |
Inhibitory |
Basophil degranulation |
Cytotoxic agents as immunomodulators |
Wagner H., Kreher B. |
Proc. of the 3rd GIRI meeting, Paris, 1989, 31- 46. |
Stimulant |
Lymphocyte growth |
Contributions of fundamental research in homeopathy |
Boiron J., Belon P. |
Berl. J. Res. Hom., 1990, 1: 34-35. |
Inhibitory |
Basophil degranulation |
Synergism of action between indoleacetic acid (IAA) and highly diluted solutions of CaCO3 on the growth of oat coleoptiles |
Bornoroni C. |
Berl. J. Res. Hom., 1991, 1 (4/5): 275-278. |
Stimulant |
Growth of plant cells |
Study of the action of Hahnemannian dilutions of mercury chloride on the mitotic index in animal cell cultures. |
Boiron J., Abecassis J., Cotte J., Bernard A.M. |
Ann. Homéop. Fr., 1991, 23: 43-49. |
Protective | Hg toxicity |
Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils |
Bellavite P., Chirumbolo S., Lippi G., Andrioli G., Bonazzi L., Ferro I. |
Cell. Biochem. Funct., 1993, 11: 231-239. |
Inhibitory |
Cell adhesion (bact. pept. 10-8-10-9) |
Effects of homeopathic preparations of organic acids and of minerals on the oxidative metabolism of human neutrophils |
Chirumbolo S., Signorini A., Bianchi I., Lippi G., Bellavite P. |
Br. Hom. J., 1993, 82: 227-244. |
Inhibitory |
Leucocyte activation (metabolism) |
Platelets/endothelial cells interactions in presence of acetylsalicylic acid at ultra low dose |
Doutremepuich C., Lalanne M.C., Ramboer I., Sertillanges M.N., De Seze O. |
Omeomed 92 (C. Bornoroni, ed.), 1993, Editrice Compositori, Bologna: 109-115. |
Inhibitory |
Prostacyclin release |
Effect of high dilutions of epidermal growth factor (EGF) on in vitro proliferation of keratinocyte and fibroblast cell lines |
Fougeray S., Moubry K., Vallot N., Bastide M. |
Br. Hom. J., 1993, 82: 124-125. |
Inhibitory |
Growth of keratinocytes |
Effects of different homeopathic potencies of Lachesis on lymphocyte cultures obtained from rabbit blood |
Enbergs H., Arndt G. |
Biol. Tier., 1993, 4. |
Stimulant |
Mitotic and immunostimulating activity (bact. pept 10-5-10-6) |
The effect of homeopathic potencies of housedust mite on the migration of house-dust sensitive human leukocytes |
Gibson S.L., Gibson R.G. |
Complement. Ther. Med., 1996, 4: 169-171. |
Stimulant |
Leucocyte chemotaxis |
The effects of Nux vomica Homaccord and Atropinum comp. on intestinal activity in vitro |
Kanui T.I., Enbergs H. |
Biol. Tier., 1996/1, 43-47. |
Stimulant |
Contraction of intestinal muscles |
Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil action: effect of cimetidine |
Sainte-Laudy J., Belon P. |
Inflamm. Res., 1997, 46: S27-S28. |
Inhibitory |
Basophil degranulation |
Effects of Podophillum pellatum compounds in various preparations and dilutions on human neutrophil functions in vitro |
Chirumbolo S., Conforti A., Lussignoli S., Metelmann H. et Al. |
Br. Hom. J., 1997; 86-16. |
Inhibitory |
Release of superoxides |
In vivo and in vitro studies on the efficiency of potentized and nonpotentized substances |
Harisch G., Dittmann J. |
BT, 1997, 2; 40-46. |
Difference between potentised and non-potentised substances |
In vivo and in vitro study; basic research |
Experiments with the effects of Ubichinon-Injeel and strong Ubichinon-Injeel on an acellular system |
Harisch G., Dittmann J. |
BM, 1997, 3; 99-104. |
Different effects of associations of various potencies and individual potencies |
In vitro study; basic research |
Efficacy of the homeopathic drugs Suis and Arnica comp.-Heel® on lymphocyte and phagocyte activity |
Enbergs H. |
BM, 1998, 1; 3-11. |
Effect of organotherapeutics and Arnica comp. - Heel® on immune system cells |
In vitro study; basic research |
Influence of dilutions and potencies of cAMP on different enzymatic systems |
Harisch G., Dittmann J. |
BM, 1998, 2; 55-62. |
Effects of dilutions and potencies of cAMP on some enzymatic activities |
In vitro study; basic research |
Studies of the principles of homeopathy; the changeover from in vivo to in vitro experimental research |
Harisch G., Dittmann J. |
BM, 1998, 3; 98-103. |
Potentised and non-potentised dilutions are equally effective, but have different actions |
Basic research |
Determination of the activity of acid phosphatase with cAMP at various potencies |
Harisch G., Dittmann J. |
BM, 1999, 1; 4-8. |
Different effects on enzymatic activity |
In vitro study; basic research |
Contribution to study of the efficacy of homeopathic potencies of phosphorus |
Gomez J.C. |
BT, 1999, 2; 53-57. |
Effect of different potencies of phosphorus |
Tests on guinea pigs |
Determination of the activity of acid phosphatase in the presence of Ubichinon comp. |
Harisch G., Dittmann J. |
BM, 1999, 4; 188-194. |
Effect of enzymatic activity of homeopathic medicine |
Basic research |
Biochemical efficacy of homeopathic and electronic preparations of D8 potassium cyanate |
Dittmann J., Kanapin H., Harisch G. |
FKM, 1999, 6; 15-18. |
Homeopathic potentisation is more effective than electronic potentisation |
Basic research |
Osteoporosis in vitro in rat tibiaderived osteoblasts is promoted by the homeopathic preparation, FMS Calciumfluor |
Palermo C., Filanti C., Poggi S., Manduca P. |
Cell Biol Int, 1999, 23(1): 31-40. |
Stimulant |
Osteogenesis (trial with compound drug) |
Thin-layer chromatography (TLC) of homeopathic active constituents |
Schmolz M. |
BM, 1999, 5; 248-250. |
Constituents of Arnica comp.- Heel® ointment: electrophoresis accelerates their skin penetration. |
Basic research |
Effect of homeopathic
constituents on enzymaticactivity. |
Basic research | |||
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Datta S., Mallick P., Bukhsh A.R. |
Complement Ther Med, 1999 Jan; 7 (8): 62-75 (a). |
Protective |
Arsenic trioxide toxicity |
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Datta S., Mallick P., Bukhsh A.R. |
Complement Ther Med, 1999 Sep; 7 (3): 156-63 (b). |
Protective |
Arsenic trioxide toxicity |
Non-cytotoxic antiviral action of a homeopathic drug |
Heine H. |
Ärzteitschrift für Neturheilverfahre, 2000; 41: 542-7. |
Stimulant |
ã interferon synthesis |
Efficacy of a potentised homeopathic drug in reducing cytotoxic effects produced by arsenic trioxide in mice |
Kundu S.N., Mitra K., Khuda Bukhsh A.R. |
Complement Ther Med , 2000 Sep; 1 (3): 157-65. |
Protective |
Arsenic trioxide toxicity |
Stimulatory effect of some plant extracts used in homeopathy on the phagocytosis induced chemiluminescence of polymorphonuclear leukocytes |
Crocnan D., Greabu M., Olinescu R. |
Rocz Akad Med Biochemist, 2000; 45: 246-254. |
Stimulant |
Phagocytosis |
Difference between the efficacy of single potencies and chords |
Dittmann J., Harisch G. |
BM, 2000, 1; 18-23. |
Potency chords are more effective than single potencies |
Basic research |
Influence of some homeopathic drugs on the catalytic activity of uricase, acid phosphatase and the cytosol glutathion-S-transferase |
Dittmann J., Kanapin H., Harisch G. |
BM, 2000, 3; 125-131 |
Effect of D8 potencies on three different enzymatic systems |
Basic research |
Influence of some homeopathic drugs on the catalytic activity of cAMP-dependent protein kinases |
Dittmann J., Kanapin H., Harisch G. |
BM, 2000, 6; 289-296. |
Effect of different potencies of 5 substances on enzymatic activity |
Basic research |
Neuroprotection from glutamate toxicity with ultra-low dose glutamate |
Jonas W., Lin Y., Zortella F. |
Neuroreport, 2001 Feb 92; 12 (2): 335-9. |
Protective | Glutamate toxicity |
KEY: BT = Biomedical Therapy
BM = Biologische Medizin
FKM = Forschung Komplementär Medizin